Genprex, Inc. Current Liabilities
Genprex, Inc. (GNPX) had Current Liabilities of $2.34 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $2.34M.
- 2026-03-31: Liabilities, Current $3.35M.
- 2025-12-31: Liabilities, Current $2.17M; Liabilities, Current as first filed $2.17M.
- 2025-09-30: Liabilities, Current $2.55M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $2.34M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.17M 10-Q · filed 2026-08-14 | $2.17M 10-K · filed 2026-03-30 |
| 2025-09-30 | $2.55M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.44M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $2.14M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.50M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.24M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $2.26M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $3.81M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $3.25M 10-K · filed 2025-04-01 | |
| 2023-09-30 | $4.34M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $3.86M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $4.84M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $2.81M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $2.46M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.15M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.38M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $1.59M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $1.16M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.05M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $613.63K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $450.72K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $375.65K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $239.79K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $697.23K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $510.68K 10-K · filed 2021-03-26 | |
| 2019-09-30 | $537.23K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $938.76K 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $231.08K 10-Q/A · filed 2019-05-20 | |
| 2018-12-31 | $387.82K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $565.39K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $300.54K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $1.43M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $830.96K 10-K · filed 2019-04-01 | |
| 2017-09-30 | $395.26K 10-Q · filed 2017-12-05 | |
| 2016-12-31 | $285.66K 10-K · filed 2018-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |